LEMTRADA
LEMTRADA (Alemtuzumab) is an FDA-approved monoclonal antibody infusion therapy indicated for the treatment of relapsing forms of multiple sclerosis (MS) in adults. Each single-dose, preservative-free 1×1.2 mL vial contains Alemtuzumab, a targeted biologic that works by binding to the CD52 antigen on the surface of immune cells, leading to their depletion and subsequent immune system reset — helping to reduce relapse rates and slow disease progression.
LEMTRADA is administered intravenously (IV) under strict medical supervision in specialized infusion settings. Its precision mechanism helps manage MS symptoms effectively in patients who have had an inadequate response to other treatments.
InfusionMed USA, located in Carrollton, Texas, provides LEMTRADA and other specialty biologic infusions to clinics, hospitals, and infusion centers across Dallas, Frisco, McKinney, Plano, The Colony, Lewisville, and surrounding North Texas regions. We ensure compliant storage, careful handling, and on-time delivery for healthcare providers.
For IV infusion use only. Store refrigerated at 2°C–8°C (36°F–46°F). Do not freeze or shake.
Download Form